This National Academies of Sciences, Engineering, and Medicine sponsored a workshop last week that was intended to explore the evidence base and research gaps relating to the implementation of the clinical practice of allowing terminally ill patients to access life-ending medications with the aid of a physician. The workshop examined what is known, and unknown, about how physician-assisted death is practiced and accessed in the United States; it was not to be a focus of the workshop to discuss at length the moral or ethical arguments for or against the practice of physician-assisted death. It was billed as a neutral space to facilitate dialogue in order to help inform ongoing discussions between patients, their providers, and other health care stakeholders. What follows is a report on that workshop.
